Literature DB >> 22442290

Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children.

Yunmei Liang1,2, Xiaorong Liu2, Hesheng Chang3,2, Lili Ji2, Guoying Huang4, Zhou Fu5, Yuejie Zheng6, Libo Wang4, Chengrong Li6, Ying Shen2, Sangjie Yu2, Kaihu Yao2, Lin Ma2, Xuzhuang Shen2, Yonghong Yang2.   

Abstract

The aim of this study was to explore the epidemiological and molecular characteristics of Streptococcus pyogenes in children from different cities in mainland China who were diagnosed with scarlet fever, impetigo and pharyngitis, as well as to detect asymptomatic carriers, between 2005 and 2008, and to compare the results with isolates from rural Chinese children with acute glomerulonephritis in 2005 and in the 1990s. Susceptibility tests to determine MICs and analysis of the presence of erythromycin-resistant genes (mefA, ermB and ermA) and emm gene typing were performed on 466 S. pyogenes isolates from Beijing, Shanghai, Chongqing and Shenzhen. Superantigen genes (speA and speC) were examined by performing PCR on isolates with the most prevalent emm genotype. All isolates were sensitive to penicillin, cefradine and ofloxacin. The highest rate of resistance was against clarithromycin (98.1 %), followed by erythromycin (97.6 %), azithromycin and clindamycin (both 97.2 %), and tetracycline (94.0 %). Among the 466 isolates, 421 (90.3 %) harboured the ermB gene, 145 (31.1 %) were speA-positive and 273 (58.6 %) were speC-positive. The speA gene was common in emm1.0 (88.8 %) and emm6.5 (83.3 %) genotypes. The speC gene was frequently observed in emm4.0 (90.0 %), emm12.0 (69.6 %), emm18.0 (66.7 %), emm22.0 (75.9 %) and emm80.0 (80.0 %) genotypes. The most prevalent emm genotypes in mainland China in recent years were emm1.0 and emm12.0. All isolates remained sensitive to β-lactams and quinolone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22442290     DOI: 10.1099/jmm.0.042309-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  20 in total

1.  Detection of Streptococcus pyogenes by use of Illumigene group A Streptococcus assay.

Authors:  Amanda M Henson; Donna Carter; Kathleen Todd; Stanford T Shulman; Xiaotian Zheng
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

2.  Changes in Macrolide Resistance Among Group A Streptococci in Serbia and Clonal Evolution of Resistant Isolates.

Authors:  Ina Gajic; Vera Mijac; Lazar Ranin; Edita Grego; Dusan Kekic; Boris Jegorovic; Aleksandra Smitran; Suncica Popovic; Natasa Opavski
Journal:  Microb Drug Resist       Date:  2018-03-20       Impact factor: 3.431

3.  Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections.

Authors:  David F Bruhn; Samanthi L Waidyarachchi; Dora B Madhura; Dimitri Shcherbakov; Zhong Zheng; Jiuyu Liu; Yasser M Abdelrahman; Aman P Singh; Stefan Duscha; Chetan Rathi; Robin B Lee; Robert J Belland; Bernd Meibohm; Jason W Rosch; Erik C Böttger; Richard E Lee
Journal:  Sci Transl Med       Date:  2015-05-20       Impact factor: 17.956

4.  Draft genome sequences of two Streptococcus pyogenes strains involved in abnormal sharp raised scarlet fever in China, 2011.

Authors:  Yuanhai You; Xianwei Yang; Yanyan Song; Xiaomei Yan; Yanting Yuan; Dongfang Li; Yanfeng Yan; Haibin Wang; Xiaoxia Tao; Leilei Li; Xihong Jiang; Hao Zhou; Di Xiao; Lianmei Jin; Zijian Feng; Ruifu Yang; Fengji Luo; Yujun Cui; Jianzhong Zhang
Journal:  J Bacteriol       Date:  2012-11       Impact factor: 3.490

Review 5.  Antibiotic prescribing for upper respiratory tract infections in the Asia-Pacific region: A brief review.

Authors:  C L Teng
Journal:  Malays Fam Physician       Date:  2014-08-31

Review 6.  Pregnancy-related group a streptococcal infections: temporal relationships between bacterial acquisition, infection onset, clinical findings, and outcome.

Authors:  Stephanie M Hamilton; Dennis L Stevens; Amy E Bryant
Journal:  Clin Infect Dis       Date:  2013-05-03       Impact factor: 9.079

Review 7.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

8.  Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012.

Authors:  T Ikebe; K Tominaga; T Shima; R Okuno; H Kubota; K Ogata; K Chiba; C Katsukawa; H Ohya; Y Tada; N Okabe; H Watanabe; M Ogawa; M Ohnishi
Journal:  Epidemiol Infect       Date:  2015-03       Impact factor: 4.434

9.  Antimicrobial activity of essential oils and carvacrol, and synergy of carvacrol and erythromycin, against clinical, erythromycin-resistant Group A Streptococci.

Authors:  Gloria Magi; Emanuela Marini; Bruna Facinelli
Journal:  Front Microbiol       Date:  2015-03-03       Impact factor: 5.640

10.  Susceptibility and emm type of Streptococcus pyogenes isolated from children with severe infection.

Authors:  Hiroshi Sakata
Journal:  J Infect Chemother       Date:  2013-05-24       Impact factor: 2.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.